MIT shares $75 million grant to fight heart disease
MIT is one of the institutions that will share the One Brave Idea Research Award to pursue new biomarkers for atherosclerosis — the hardening of the arteries that kills about 500,000 people in the United States every year. The American Heart Association (AHA), Verily Life Sciences (formerly Google Life Sciences), and AstraZeneca launched the One Brave Idea program earlier this year, and the winners of the five-year, $75 million award were announced today. At the core of the proposal is a collaboration between the Brigham and Women’s Hospital and MIT. The research team will be led by Calum MacRae, chief of cardiovascular medicine at Brigham and Women’s Hospital, and the MIT effort will be led by Elazer R. Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology in MIT’s Institute for Medical Engineering and Science. Edelman also directs the Harvard-MIT Biomedical Engineering Center and the MIT Clinical...